Could a drug make milk allergy therapy safer and more effective?

NCT ID NCT04148352

Terminated Disease control Sponsor: Andrew J Long, PharmD Source: ClinicalTrials.gov ↗

First seen Jan 08, 2026 · Last updated May 02, 2026 · Updated 28 times

Summary

This study tested whether adding dupilumab (a drug that reduces allergic inflammation) to milk oral immunotherapy (gradually eating small amounts of milk protein) helps people with cow's milk allergy tolerate more milk with fewer side effects. The trial included 33 people aged 4 to 50 years. The goal was to see if more participants could safely consume at least 2040 mg of milk protein after 18 weeks of treatment. The study was terminated early, so results are limited.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ALLERGIES FOOD MILK are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Show contact details

Locations

Mayo Clinic

Scottsdale, Arizona, 85259, United States
Phoenix Children's Hospital

Phoenix, Arizona, 85016, United States
Sean N. Parker Center for Allergy & Asthma Research at Stanford University

Palo Alto, California, 94304, United States

Conditions

Explore the condition pages connected to this study.

ALLERGIES FOOD MILK